Related Experiment Video
Updated: Feb 7, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Characterization of macrolide-resistant non-invasive pneumococci in the pre-vaccine era in Serbia
Suncica Popovic1, Mirjana Hadnadjev2, Ina Gajic1
11 Institute of Microbiology and Immunology, Medical Faculty University of Belgrade , Belgrade, Republic of Serbia.
Abstract:
Numerous reports have confirmed that increased macrolide use in the treatment of respiratory tract infection has contributed to the emergence of antibiotic resistance worldwide. Studies have also shown that pneumococcal vaccine can reduce pneumococcal resistance. The aim of this study was to determine the prevalence of co-resistance to penicillin and other antibiotics in macrolide-resistant (MR) non-invasive pneumococcal isolates and to evaluate serotype distribution in resistant strains in the pre-vaccine era in Serbia. About 80% of MR isolates expressed the MLS phenotype with very high resistance to both erythromycin and clindamycin. A total of 132 (84.1%) MR isolates were multiresistant, i.e., they were resistant to erythromycin, penicillin, tetracycline, and trimethoprim-sulfamethoxazole. Among 157 MR pneumococci, 11 different serotypes were found. Four serotypes, 19F, 14, 6B, and 23F, accounted for 77.7% of all MR pneumococcal isolates. Among isolates with the cMLS phenotype, serotypes 19F and 14 were predominant, whereas serotype 6A was the most common among those with the M phenotype, followed by 14. In conclusion, co-resistance to macrolides and penicillin in our non-invasive pneumococcal isolates is high. The majority of tested strains (∼80%) belonged to the four serotypes (19F, 14, 6B, and 23F) that are included in all conjugate vaccine formulations.
Insights
High co-resistance to macrolides and penicillin was found in pneumococcal isolates in Serbia. Most resistant strains belonged to serotypes included in conjugate vaccines, highlighting a significant public health concern.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Increased macrolide use drives antibiotic resistance in respiratory infections.
- Pneumococcal vaccines are known to reduce antibiotic resistance.
- Understanding resistance patterns is crucial for effective treatment and prevention.
Purpose of the Study:
- To determine co-resistance to penicillin and other antibiotics in macrolide-resistant pneumococci.
- To evaluate serotype distribution among resistant strains in Serbia's pre-vaccine era.
- To assess the prevalence of multiresistance in macrolide-resistant pneumococcal isolates.
Main Methods:
- Phenotypic characterization of macrolide resistance (MLS, M phenotypes).
- Antimicrobial susceptibility testing for penicillin, erythromycin, clindamycin, tetracycline, and trimethoprim-sulfamethoxazole.
- Serotyping of 157 macrolide-resistant Streptococcus pneumoniae isolates.
Main Results:
- Approximately 80% of macrolide-resistant isolates exhibited MLS phenotype with high resistance to erythromycin and clindamycin.
- 132 (84.1%) isolates were multiresistant, showing resistance to erythromycin, penicillin, tetracycline, and trimethoprim-sulfamethoxazole.
- Four serotypes (19F, 14, 6B, 23F) constituted 77.7% of macrolide-resistant isolates, all included in current conjugate vaccines.
Conclusions:
- High co-resistance to macrolides and penicillin is prevalent in non-invasive pneumococcal isolates.
- The predominance of vaccine-included serotypes among resistant strains underscores a significant challenge.
- Findings emphasize the need for ongoing surveillance of antibiotic resistance patterns in pneumococci.
More Related Videos
06:52Characterizing Herbivore Resistance Mechanisms: Spittlebugs on Brachiaria spp. as an Example
Published on: June 19, 2011
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
Related Concept Videos
Vaccinations
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Resistivity
Resistance